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While the effects of instantaneous, single-bout exposure to hypoxia have been well researched, little is known about 
the autonomic response during, or as an adaptation to, repeated intermittent hypoxic exposure (IHE) in a sedentary 
population. Resting heart rate variability (HRV) and exercise capacity was assessed in 16 participants (8 receiving 
IHE, [Hyp] and 8 receiving a placebo treatment [C]) before and after a 4-week IHE intervention. Heart rate variability 
was also measured during an IHE session in the last week of the intervention. Post-intervention, the root mean 
squared successive difference (rMSSD) increased substantially in Hyp (71.6 ± 52.5%, mean change ± 90% 
confidence limits) compared to C suggesting an increase in vagal outflow. However, aside from a likely decrease in 
submaximal exercise heart rate in the Hyp group (–5.0 ± 6.4%) there was little evidence of improved exercise 
capacity. During the week 4 IHE measurement, HRV decreased during the hypoxic exposure (reduced R-R interval: 
–7.5 ± 3.2%; and rMSSD: –24.7 ± 17.3%) suggesting a decrease in the relative contribution of vagal activity. 
In summary, while 4 weeks of IHE is unlikely to improve maximal exercise capacity, it may be a useful means of 
increasing HRV in people unable to exercise.
Keywords: autonomic nervous system, sedentary lifestyle, interval hypoxia, simulated altitude, physical fitness, 
health
Heart rate variability (HRV) is the analysis of the variation in the beat to beat intervals in the 
heart rhythm, which reflects the autonomic nervous system (ANS) innervation on the sinus 
node (25). Heart rate variability is also responsive to the changes in the ANS associated with 
external stimuli such as real or simulated altitude (21). For example, an initially sharp increase 
in sympathetic activity is observed upon arrival at altitude (7, 28), which gradually declines 
through the acclimatization process (14, 23). The reduction in HRV is largely due to a 
reduction in the parasympathetic drive at the sinus node during hypoxia, the mechanism 
behind which has been well described by Roche et al. (20). The recovery of HRV to baseline 
levels upon return to normoxic ambient air depends on the length and severity of the initial 
exposure. That is, after 12 hours of continuous hypoxic exposure, a pronounced (dampened) 
effect on HRV is still evident an hour after returning to normoxic ambient air (7), but after a 
brief hypoxic exposure of 15 min, recovery is almost immediate (20). 
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Simulated altitude procedures are used in both athletes (2, 9) and non-athletes (4, 8) 
alike. However, while the acute effects of single or continuous hypoxic exposures have been 
well-documented, the autonomic response during repeated bouts of intermittent hypoxic 
exposure (IHE) is currently unknown. Moreover, while IHE has been suggested as a safe 
means of improving exercise economy (4) and baroreflex sensitivity (8) in participants with 
cardiovascular disease, little is known about the training effect of IHE on HRV in a sedentary, 
middle aged population. The aim of this research was to investigate the instantaneous and 
adaptive effects of 4 weeks of IHE on HRV in a sedentary, middle aged population. As a 
dampened HRV is associated with poorer coronary health (4), an intervention that serves to 
increase HRV may have a restorative effect on cardiac health.
Materials and Methods
Participants
Inclusion criteria involved engaging in less than 30 min of physical activity on most days of 
the week (6), but otherwise generally healthy and aged between 45–60 years. Exclusion 
criteria included uncontrolled hypertension or cholesteraemia, any condition where peripheral 
oxygen saturation (SpO2) is already compromised, melanoma, pregnancy, or by their own or 
the screening physician’s discretion. Following a health assessment, 16 participants were 
randomly selected into either a group receiving IHE treatments (Hyp) (n = 8; age: 56.5 ± 5.5 
years; 3 males, 5 females; height: 171.0 ± 10.1 cm; weight: 82.3 ± 13.5 kg; body fat: 33.5 ± 
4.5%; mean ± s) or a placebo (C) (n = 8; age: 56.1 ± 5.1 years; 2 males, 6 females; height: 
164.6 ± 8.4 cm; weight: 81.3 ± 27.2 kg; body fat: 35.2 ± 12.9%). Participants remained blind 
to their groups throughout the study. All participants signed a written informed consent prior 
to participation. This study was approved by the local University Human Ethics Committee.
Baseline and post-intervention testing
Quantification of physical activity at baseline and post intervention was completed using the 
International Physical Activity Questionnaire, long-format (IPAQ-LF), and a 4-day diary 
detailing nutritional intake, sleep, mood, medication and physical activity. Participants were 
asked to replicate these on subsequent testing days. At baseline, participants were familiarised 
with the testing equipment and procedures, and anthropometric data was collected including 
body composition and weight (InBody230, Biospace Co. Ltd., Seoul, South Korea), height 
and age.
Resting heart rate, heart rate variabilty, and systolic blood pressure
During the last 5 minutes of a 10-minute resting period, heart rate (HR), HRV and systolic 
blood pressure (SBP) were measured. Heart rate variability was detected using a heart rate 
monitor (RS800CX, Polar Electro Oy, Kempele, Finland) and belt (Wearlink W.I.N.D, Polar 
Electro Oy, Kempele, Finland) and analysed using Polar software (Polar ProTrainer 5, 
Version 5.41.000). To measure heart rate variability, the root mean square of successive 
differences in the RR interval (rMSSD) and RR interval were used to provide an indication 
of vagal outflow. These measures are more resistant to breathing artefact than alternative 
analyses (18). However, to provide a more complete dataset, and to enable greater com-
parability with other research, the standard deviation of N-N intervals (SDNN) and high 
frequency (HF: 0.15 – 0.4 Hz) measurements were also reported. 
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As HRV can have low repeatability (27) all data were filtered for ectopic beats using the 
Polar ProTrainer 5 (PPT5) filters (using default settings of moderate filter power and minimum 
protection zone of 6 bpm). Data were then visually inspected and any remaining ‘spikes’ in 
the data were removed and replaced with the next appropriate RR interval. The detection of 
RR intervals using similar Polar heart rate technology has been validated against 12-lead 
ECGs (19) however, there is uncertainty regarding the ability of the PPT5’s error correction 
function to detect non-sinus originating beats which can result in inflated results (29). 
Therefore, all data were screened for outliers using the Median Absolute Deviation (30), and 
participants with greater or less than 3 × the population standard deviation as estimated by the 
median (17) were excluded from the data. Two participants in the hypoxic group (Hyp) were 
excluded from the resting HRV analyses due to equipment malfunction (n = 1), and an 
rMSSD outlier (n = 1, rMSSD was 101.9 ms at baseline). The natural logarithm of the rMSSD 
(18) was calculated to further reduce the impact of spontaneous respiration, and to improve 
the accuracy of the measurements. 
Blood pressure
Blood pressure was measured continuously throughout rest and exercise using plethysmo-
graphy to detect brachial arterial pressure in the finger (MLE1054-V Finometer MIDI, 
Finapres Medical Systems, The Netherlands). Data were recorded using BeatScope Easy® 
software (Finapres Medical Systems, The Netherlands). 
Oxygen consumption during rest and exercise
Respiratory gases were collected through a facemask that allowed simultaneous respiration 
via the nose and mouth (Hans Rudolph, Kansas City, MO, USA), and measured using a 
breath-by-breath gas analysis system (MetaMax® 3B; Cortex Biophysik, Leipzig, Germany). 
Prior to each battery of tests, the gas analyser was calibrated against 15% oxygen and 5% 
carbon dioxide. Volume was calibrated daily (Hans Rudolph 5530 3 L syringe; Kansas City, 
MO, USA). 
A modified submaximal Astrand protocol (24) was used to measure submaximal oxygen 
uptake (V̇O2submax) and to predict V̇O2peak. Participants started pedalling at 50 rpm on a cycle 
ergometer starting at a workload of 25 Watts (W) (Monark Ergomedic 818E, Sweden). 
Resistance increased by 25 W every 2 min until the participant reached 70% of their age 
predicted maximum heart rate ((220 – age)*0.7) (24). Participants then continued to cycle at 
the same workload for an additional 2 min, and then until steady state (≤ 5 bpm between 
consecutive min) was achieved. 
Breath-by-breath data was exported to an Excel spreadsheet for visual inspection and 
any outlying data points were removed. The last 5 min of the 10 min resting interval, and the 
last 30 s of the 2 min 50 W exercise stage were selected, averaged and reported as oxygen 
consumption per min, per kg of body mass (ml·min-1·kg-1) for resting and V̇O2submax measures, 
respectively. Heart rate and RPE were measured at the end of the 50 W stage and used to 
indicate submaximal heart rate (HRsubmax) and rating of perceived exertion (RPE50W), 
respectively. The mean of the 70% age-predicted steady state HR recordings and the final 
workload were used to predict V̇O2peak using the Astrand-Rhyming nomogram and age 
correction factor. Steady-state heart rates of ≤ 112 bpm were excluded from the analysis as 
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their predicted V̇O2peak could not be accurately measured using the Astrand nomogram. Time 
domain analyses of HRV can be unreliable during exercise (22), therefore no exercise-related 
HRV was analysed.
Intermittent hypoxic exposure
During the 4-week intervention, participants received six 5-min intervals of hypoxic (or 
placebo) air delivered through a face mask (QuadraLite Facemask, Intersurgical, Intermed, 
Auckland, New Zealand) interspersed with six 5-min periods of breathing normoxic ambient 
air, 4 times per week during seated rest. To improve the single blind nature of the study 
and prevent the participants from guessing whether they were in the test or control group, 
a progressive decrease in the fraction of inspired oxygen (FiO2) was used in the test 
group. Hypoxic air (Compressor Twin, GO2Altitude, Biomedtech, Victoria, Australia) was 
controlled such that: Hyp: week 1: SpO2 = 95% (FiO2 ~ 0.21); week 2: 90% (FiO2 ~ 0.16); 
week 3: 85% (FiO2 ~ 0.13); and week 4: 80–85% (FiO2 ~ 0.10–0.12); C: SpO2 > 95% in week 
1–4. Peripheral oxygen saturation was monitored using finger pulse oximetry (Nonin Pulse 
Oximeter, Plymouth, Minnesota). During week 4, HRV and HR were recorded during each 
participant’s intervention session to ascertain instantaneous ANS response to a full IHE (or 
placebo) session. Heart rate and HRV measured during the last 2 min of each 5 min interval 
were extracted and averaged. The average HR and HRV during the hypoxic and placebo air 
intervals were then compared. See Fig. 1 for an outline of the testing protocol.
Throughout the intervention period participants maintained a diary to record any 
intervention-related comments. Similar themes in the comments were identified and the total 
number of referrals to the theme were counted, as was the greatest contribution made by one 
participant. This was done to identify where repetitive comments by one participant could 
have skewed the data. 
Fig. 1. Testing protocol before, during and after the intervention period.
Statistical analysis
Statistical analysis was performed using a pre–post parallel groups spreadsheet designed to 
compute the magnitude of the smallest worthwhile change between groups using a 90% 
confidence interval (12). The smallest worthwhile change was determined using Cohen’s 
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value of 0.2 of the mean difference divided by the between-subject standard deviation. The 
confidence interval indicates the range of uncertainty of the true value. For a mechanistic 
inference (in the case of IPAQ-LF, HRV and HR) if the confidence interval overlaps both 
substantially increased and substantially decreased values, the effect is ‘unclear’. In all other 
cases, the outcome is ‘clear’ and a statement based on the percent chance of the outcome is 
given (increased/trivial/decreased). Probabilistic inferences for the qualitative outcome were 
assigned using the following criteria: <0.5% = most unlikely; 0.5–5% = very unlikely; 5–25% 
= unlikely; 25–75% = possibly; 75–95% = likely, 95–99.5% = very likely, >99.5% = most 
likely (13). 
For variables directly affecting health or performance (exercise economy, SBP and 
predicted V̇O2peak), a clinical analysis was performed. In this analysis, if the potential for 
benefit was acceptable but the risk of harm was too high, the effect is ‘unclear’. An odds ratio 
of benefit: harm was accepted if the ratio was <66%. In the case of a clear outcome, a 
statement of the likelihood that the changes were beneficial/trivial/harmful was made. In this 
way, the risk of making a Type 1 clinical error (using a harmful effect) is prioritised over a 
Type 2 error (not using a beneficial effect).
Data was log transformed prior to analysis to reduce non-uniformity of error and 
displayed as a percent. Baseline values were used as a covariate in all analyses to avoid the 
effect of regression to the mean, and bias associated with uneven baseline averages (12). All 
results are expressed as mean change (%) ± 90% confidence interval. Unless reported in 
Table I, this is followed by the percent chances that the change has substantially increased/ is 
trivial/ has substantially decreased (in the case of the mechanistic analyses) or is beneficial/ 
trivial/ harmful (in the case of clinical analyses). Finally, the qualitative outcome is reported.
Results
Raw data are presented in Table I. Although continuous blood pressure was measured, the 
average over the last 5 minutes of the 10 minute rest period was used as noise and artefact in 
the continuous recording impacted the reliability of the data.
As a result of 4 weeks of IHE, resting HR in the Hyp group decreased compared to the 
C group (–10.4 ± 8.7%). Resting HRV increased substantially in the Hyp group compared to 
the C group (rMSSD: 71.6 ± 52.5% see Fig 2, RR-interval: 7.8 ± 8.1%, HF: 241.7 ± 143%) 
following the 4 weeks of IHE treatment. However, there were no clear changes in SDNN 
(11.8 ± 41.9%), SBP (–3.4 ± 8.4%), or resting oxygen consumption (V̇O2rest: –0.7 ± 16.9%) 
between groups.
One participant in the Hyp group was excluded from all exercising oxygen consumption 
measurements due to missing post-intervention data. All participants completed the 50 W 
submaximal stage. There were no clear changes in V̇O2submax or RPE50 W between groups at 
a 50 W workload (V̇O2submax: –0.1 ± 13.9%; RPE50 W: –5.0 ± 13.0%), however, the Hyp 
group demonstrated a likely decrease in HRsubmax (–5.0 ± 6.4%) compared to the C group. Two 
participants in each group were excluded from the peak oxygen uptake (V̇O2peak) predictions 
as their steady state HR was less than 112 bpm. Changes in estimated V̇O2peak between groups 
as a result of IHE training were trivial (0.8 ± 7.0%). 
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Table I. Baseline and post intervention resting and exercising mechanistic and clinical variables
Hyp pre Hyp post C pre C post Qualitative outcome  
(% chance of increase, 





(beats·min-1) 59.2 ± 7.4 57.8 ± 6.2 64.38 ± 9.8 67.4 ± 8.2 Likely decreased (1/6/94)
RR-interval 
(ms) 1029 ± 135 1049 ± 118 955 ± 164 921 ± 116 Likely increased (83/16/2)
rMSSD (ms) 30.7 ± 11.9 35.6 ± 8.1 23.1 ± 10.9 21.8 ± 11.0 Very likely increased (95/3/1)
HF (Hz) 402.7 ± 302.6 470.6 ± 217.2 234.1 ± 150.7 235.7 ± 255.4 Very likely increased (97/2/1)
SDNN 39.2 ± 11 45.0 ± 14.5 29.8 ± 11.0 35.1 ± 15.9 Unclear (56/27/17)
Clinical variables
SBP (mmHg) 120.7 ± 19.5 122.6 ± 21.0 109.4 ± 12.7 117.0 ± 11.8 Unclear (9/37/54)
V̇O2rest 
(ml·min-1·kg-1) 3.1 ± 1.1 3.3 ± 0.5 2.9 ± 0.7 3.4 ± 0.7 Unclear (24/46/30)
Exercise
V̇O2submax 
(ml·min-1·kg-1) 10.0 ± 1.8 11.0 ± 1.7 11.3 ± 1.8 12.1 ± 2.2 Unclear (31/38/32)
HRsubmax 90.3 ± 8.7 86.3 ± 7.9 90.8 ± 14.0 91.0 ± 12.7 Likely decreased (2/23/75)




23.6 ± 2.5 23.5 ± 2.6 25.0 ± 10.0 24.9 ± 10.8 Likely trivial (9/86/5)
Data are mean ± SD, Qualitative outcome is expressed as: % chance of increase/trivial/decrease for mechanistic 
variables, and % chances of beneficial/trivial/harmful in clinical variables. Hyp: Hypoxic exposure group;  
C: control group; Pre: baseline recording; Post: 1–3 days post intervention; HR: Heart rate; RR-interval: Average 
interval between R to R peaks in the HR trace; rMSSD: Root mean square successive difference; SBP: Resting 
systolic blood pressure; V̇O2rest: Oxygen uptake during rest; V̇O2submax: oxygen uptake during the last 30 s of the 
50 W interval; HRsubmax: average heart rate taken at the end of each min during the 50W exercise interval; RPE50 
W: average rating of perceived exertion taken that the end of the 50 W exercise interval; predicted V̇O2peak: peak 
oxygen uptake predicted using Astrand nomogram
During the week-4 HRV and HR assessments, there was a substantial decrease in rMSSD 
and the RR-interval, and an increase in HR when participants in the Hyp group went from 
breathing ambient air to hypoxic air (rMSSD: 30.0 ± 2.6 ms to 25.4 ± 1.8 ms; RR-interval: 
976 ± 20 ms to 883 ± 16 ms; HR: 62.4 ± 1.5 bpm to 68.2 ± 1.3 bpm) compared to the C group 
who went from breathing placebo to ambient air (rMSSD: 18.2 ± 1.5 ms to 20.3 ± 2.1 ms; 
RR-interval: 970 ± 16 ms to 950 ± 35 ms; HR: 62.4 ± 1.2 bpm to 63.6 ± 2.6 bpm). The 
differences between groups in these variables are as follows: rMSSD: –24.7 ± 17.3%, 1/1/98, 
very likely decreased; RR-interval: –7.5 ± 3.2%, 0/0/100, most likely decreased; HR: 8.8 ± 
3.4%, 100/0/0, most likely increased (see Fig 3).
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Fig. 2. Root mean square of successive differences (rMSSD) at baseline and post-intervention 
Legend: Thin lines indicate individual responses; thicker lines indicate the group average  
(which are also indicated numerically on either end of the mean line).  
Hyp: group receiving hypoxic air during intermittent hypoxic treatments; C: Control Group receiving normoxic 
(placebo) air during intermittent hypoxic treatment; rMSSD: root mean square successive difference.
Fig. 3. Heart rate and rMSSD responses during a typical week 4 intermittent hypoxic exposure session
Legend: Hyp: group receiving hypoxic air during intermittent hypoxic treatments; Control: Group receiving 
normoxic (placebo) air during intermittent hypoxic treatment. rMSSD: Root mean square successive difference; 
HR: Heart rate; IHE: Intermittent hypoxic exposure; HE: 5-min hypoxic exposure interval;  
Rest: 5-min ambient air interval; NE: 5-min normoxic (placebo) interval. Lined areas indicate the hypoxic  
or normoxic placebo intervals. Thin lines indicate individual participant results, whereas the thicker lines indicate 
the group mean.
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The most frequently reported comments relating to the IHE sessions were “fine” and 
“tired”. More participants in Hyp than C reported breathing discomfort (usually regarding an 
absence of “enough air”) or headaches (Fig 4).
There were no clear changes in physical activity (total METS) between groups over the 
course of the study. Food and activity diaries indicated that participants had not deviated 
substantially in their day-to-day nutrition, medication or physical activity habits during the 
study.
Fig. 4. Frequencies of recurring comments from participants regarding the hypoxic/normoxic exposure  
recorded in notebooks over the course of the 4-week intervention period
Legend: Black and white bars on the left represent proportions from the control group, while lined and  
crossed bars on the right represent proportions from the hypoxic group. As these bars indicate the total number  
of times the comment was made over the 4-week intervention, irrespective of whether it was from 1 person 
repeatedly, or many people once, the value of the highest contribution by one person has been indicated  
(black and crossed sessions, respectively). C: control group receiving normoxic (placebo) air during intermittent 
hypoxic treatments. Hyp: group receiving hypoxic air during intermittent hypoxic exposure.
Discussion
The results of this study indicate that although the typical response to breathing hypoxic air 
is associated with decreased HRV (reflecting increased SNS), the subsequent adaptation 
following 4 weeks of IHE is associated with increased HRV. To our knowedge, this is the first 
study to look at the instantaneous and adaptive response of the ANS to repeated hypoxic 
exposure intervals in a sedentary population.
The overall increase in resting HRV following 4 weeks of IHE is likely an adaptive 
response to the repeated stress stimulus of the the hypoxic intervals. Indeed, in a similar study 
in healthy army recruits, 2 weeks of IHE training resulted in reduced vagal withdrawal during 
the hypoxic exposure suggesting improved tolerance to the hypoxic stress (1). However, no 
changes in resting HRV were noted in these participants, which could have been due to the 
short intervention period. 
As anticipated, the HF outcomes were very similar to the rMSSD as these two measures 
are highly correlated to each other. The SDNN measurements reflect both short and long-
term components of HRV (26). In this regard, the short 5-min recordings in our study would 
have limited the capture of long term cyclic components of the HRV and likely contributed 
to the ‘unclear’ statistical outcome.
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While we did not detect any improvement in estimated V̇O2peak or V̇O2submax, we did 
notice lower HR during submaximal (50 W) exercise. Interestingly, in addition to improved 
HRsubmax, Burtscher et al. (3) reported significantly lower SBP, HR, and RPE in the group 
receving IHE following his 3-week intervention. The greater improvement in V̇O2submax in 
Burtscher et al. (3) study participants compared to our participants may be attributed to the 
lower baseline health of the individuals in their study. However, like Burtscher et al. (3), 
despite the improvement in HRsubmax, we did not detect any change in V̇O2submax between the 
groups, which suggests that IHE seems to improve submaximal HR but has an unclear effect 
on oxygen efficiency. 
As with the resting rMSSD, the decreased HRsubmax may be associated with the increased 
stress tolerance to the hypoxic exposures yielding reduced vagal withdrawal demonstrated by 
lower heart rate during physiological stress. Alternatively, haemodynamic adaptation, such as 
incresed total haemoglobin mass, may account for the reduction in HRsubmax. While this has 
been discovered in similar studies (3), haemodynamic parameters were not measured in this 
study. However, it would be expected that with improved haemodynamics, improvement 
in V̇O2submax and V̇O2peak would result (5). Therefore, in our participants it is likely that the 
reduced HRsubmax with no apparent change in V̇O2submax or V̇O2peak is as a result of improved 
autonomic stress tolerance and reduced vagal withdrawal during light or moderate exercise.
During the hypoxic intervals, there was a substantial decrease in rMSSD, which supports 
the findings of other researchers (7, 15, 16, 21). What was interesting, however, was the large 
variation in the individual HRV response to the IHE intervals (see Fig. 3). The measurement 
of rMSSD reflects vagal modulation which is largely related to the respiratory sinus 
arrhythmia and therefore can be influenced by breathing frequency (10). Given that there can 
be substantial individual variation in the hypoxic ventilatory response (11), the change in 
breathing frequency with hypoxic exposure may be responsible for the decrease in rMSSD, 
rather than autonomic change. However, while Penttilä et al. (18) did note a decrease in 
rMSSD with increased breathing frequency, these differences were not statistically significant, 
and therefore the decrease in rMSSD during hypoxic exposure in our study is likely to 
predominantly reflect vagal withdrawal, rather than change in respiration. 
In addition to the high level of autonomic variation between participants, there was also 
a wide variation in the nature of the subjective reponses in the participants which were 
collected in session by session comment books. For example, while most of the participants 
tolerated the hypoxic intervals well (see “fine” or “no comment” in Fig. 4), a number of the 
Hyp group detailed mild side effects during the hypoxic interval (such as having an urge to 
breath faster or more deeply, see “breathing” in Fig. 4). One participant, however, noted 
headaches, chest pain and blurry vision during the hypoxic exposure interval (note the much 
higher “highest contributor” portion in the “headache” and “other” bars in Fig. 4). On the 
advice of the physician, the participant in question stopped the hypoxic interval at the onset 
of any of these symptoms and only continued with the IHE session following full recovery, 
and if so desired by the participant. On all occasions, the symptoms were abated following a 
short return to ambient air and the participant was happy to continue the session. The session 
was continued at a previsouly well tolerated FiO2. 
Limitations
The small sample sizes (Hyp: n = 8, and C: n = 8), and the necessity to exclude some of the 
data due to erronous or incomplete datasets increase the risk of Type 1 errors, and reduced the 
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extent to which these results can be applied to other populations. Therefore, caution should 
be used when interpreting these results until the findings can be repeated in a larger population.
Participants were encouraged to be as inclusive as possible when using their comment 
books, but this notetaking was not monitored. Consequentially, some participants may have 
recorded data unrelated to the hypoxic exposure, while others neglected to complete the 
comment books altogether. A focus group debriefing session, or open-ended interview would 
provide more structured feedback. 
In conclusion, four IHE sessions per week for 4 weeks resulted in increased HRV in 
sedentary, middle-aged adults, and lowered their submaximal exercising HR. However, the 
IHE intervention did not demonstrate any beneficial effect on aerobic metabolism. If these 
findings are confirmed in a larger cohort, IHE may prove to be a useful technique for people 
requiring autonomic stimulation but who are unable to exercise, such as those confined to bed 
rest or those with cardiovascular disease.
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